These findings identify FBXW7 as a critical mediator of antitumor immunity in MSS CRC, and suggest that inhibiting SET to restore FBXW7 function, in combination with immune checkpoint blockade, offers a promising strategy for otherwise immune checkpoint blockade–refractory MSS CRC [28]. This evidence concerns the gene FBXW7 and Marinesco-Sjogren syndrome.